[Form 4] ARGAN INC Insider Trading Activity

Rhea-AI Filing Summary

Karen A. Sweeney, a director of ARGAN INC (AGX), reported a sale of company stock on September 19, 2025. She sold 390 shares of the issuer's common stock on the open market at a price of $264.25 per share and after the transaction beneficially owned 1,315 shares directly. The Form 4 was signed by the reporting person on September 22, 2025. The filing records the transaction type as an open-market sale and specifies direct ownership following the sale.

Positive

• Director remains a direct shareholder with 1,315 shares following the sale
• Full Section 16 disclosure provided including date, price, quantity, and signature

Negative

• Director sold 390 shares on 09/19/2025, reducing their direct stake
• Sale was on the open market, indicating realized insider liquidity

Insights

Financial Analyst

TL;DR: A single open-market sale of 390 shares by a director; remaining direct holding is 1,315 shares.

The reported sale on 09/19/2025 of 390 shares at $264.25 is a straightforward disclosure of insider liquidity. The Form 4 shows direct ownership of 1,315 shares after the sale, which quantifies the director's residual stake. This filing does not provide information on the director's broader holdings, trading pattern, or motivations, and contains no company operational or financial metrics.

Corporate Governance Expert

TL;DR: Routine director sale disclosed; filing documents compliance with Section 16 reporting requirements.

The Form 4 documents compliance with Section 16 reporting by a director who executed an open-market sale. The disclosure includes transaction date, price per share, shares sold, and resulting direct ownership, and is signed by the reporting person. There are no indications in the filing of related-party transactions, derivative activity, or plan-based transactions that would require additional disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweeney Karen

(Last) (First) (Middle)

22550 CALVERTON ROAD

(Street)

SHAKER HEIGHTS OH 44122

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/19/2025		S		390(1)	D	$264.25	1,315	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On September 19, 2025, the Reporting Person sold 390 shares of the Issuer's common stock on the open market at a price of $264.25 per share.

	/s/ Karen A. Sweeney	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the ARGAN INC (AGX) Form 4 report?

The Form 4 reports an open-market sale of 390 shares of ARGAN INC common stock on 09/19/2025 at $264.25 per share.

How many ARGAN INC (AGX) shares does the reporting director own after the sale?

The reporting person beneficially owned 1,315 shares directly following the reported transaction.

Who filed the Form 4 for AGX and when was it signed?

The Form 4 was filed by Karen A. Sweeney, a director, and the form bears her signature dated 09/22/2025.

At what price were the AGX shares sold in the reported transaction?

The sale price reported for the transaction was $264.25 per share.

Does the Form 4 indicate any derivative transactions or plan-based trades?

No. The filing lists only a non-derivative open-market sale and does not report derivative securities or plan-based transactions.